Table 4.
Univariatea | Multivariableb | |
---|---|---|
Invasive mechanical ventilation | ||
Women | Ref | Ref |
Men | 1.24 (95% CI 0.59–2.58) | 1.16 (95% CI 0.54–2.50) |
Invasive monitoring | ||
Women | Ref | Ref |
Men | 1.67 (95% CI 0.54–5.14) | 1.72 (95% CI 0.55–5.33) |
Vasoactive treatment | ||
Women | Ref | Ref |
Men | 1.46 (95% CI 0.94–2.26) | 1.50 (95% CI 0.96–2.33) |
Echocardiography | ||
Women | Ref | Ref |
Men | 1.14 (95% CI 0.79–1.65) | 1.16 (95% CI 0.80–1.68) |
RRT | ||
Women | Ref | Ref |
Men | 1.32 (95% CI 0.74–2.34) | 1.39 (95% CI 0.77–2.50) |
Central catheters | ||
Women | Ref | Ref |
Men | 1.59 (95% CI 1.04–2.42) | 1.60 (95% CI 1.04–2.45) |
Levosimendan | ||
Women | Ref | Ref |
Men | 2.04 (95% CI 1.24–3.37) | 2.11 (95% CI 1.27–3.49) |
a536 and 529 patients are included in univariate analyses and multivariable analyses respectively.
bAdjusted for Age, Estimated mortality risk and Charlson Co-morbidity index.
RRT Renal replacement therapy.